S Gastrointestinal And Liver Disease 12th Edition _top_ – Direct

: New dedicated chapters address Gastrointestinal and Hepatic Manifestations of Coronavirus Infection (COVID-19) and Enterocolitis and Hepatitis Induced by Cancer Immunotherapy .

A dedicated expansion covers the integration of computer-aided detection (CADe) and computer-aided diagnosis (CADx) during colonoscopy and upper endoscopies. The text provides parameters for utilizing , improve mucosal visualization, and minimize adenoma miss rates in clinical oncology screening. 2. Reclassification of Steatotic Liver Disease (MASLD)

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease provides several benefits to healthcare professionals, including: s gastrointestinal and liver disease 12th edition

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Share public link

: Global customer reviews on Amazon average 4.1 out of 5 stars , with high praise for its informative depth, though some international buyers have noted logistical issues like receiving only one volume of the two-volume set. Purchase Information AI responses may include mistakes

: Features over 1,100 full-color illustrations and more than 20 procedural videos accessible via the included eBook at Elsevier . Product Details Information Release Date December 10, 2025 Format 2-Volume Set (Hardcover or Digital) Page Count Approximately 2,560 pages Publisher Elsevier Health ISBN-13 978-0443116575

The 12th edition is available as a two-volume hardcover set and as an eBook, published by Elsevier. The core details are as follows: viral hepatitis (B & C)

Algorithms for acute abdominal pain, dyspepsia, obscure GI bleeding, and jaundice.

: Offers clear, algorithmic decision trees that optimize patient outcomes and streamline clinical workflows.

MASLD, viral hepatitis (B & C), portal hypertension, cirrhosis management, and transplant updates.

: Addresses contemporary challenges with new chapters on the GI and hepatic manifestations of Coronavirus and enterocolitis induced by cancer immunotherapy .